| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Transplantation Biology Research Center and
Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129
It has previously been demonstrated that xenograft rejection in rodents is dependent on CD4+ T cells. However, because of the lack of an appropriate in vivo model, little is known about the cellular basis of human T cell-mediated rejection of xenografts. In this study, we have evaluated the ability of human T cells to mediate rejection of porcine skin grafts in a novel in vivo experimental system using immunodeficient mice as recipients. Recombinase-activating gene-1-deficient mice (R-) lacking mature B and T cells were grafted with porcine skin and received human lymphocytes stimulated in vitro with irradiated porcine PBMC. Skin grafts on mice given either unseparated, activated human lymphocytes, or NK cell-depleted lymphocyte populations were rejected within 18 days after adoptive cell transfer. In contrast, skin grafts on mice given T cell-depleted human lymphocytes or saline showed no gross or histologic evidence of rejection up to 100 days after adoptive transfer. Purified CD4+ T cells were also able to mediate rejection of porcine skin grafts. These data suggest that human CD4+ T cells are sufficient to induce rejection of porcine xenografts. Thus, strategies directed toward CD4+ T cells may effectively prevent cellular rejection of porcine xenografts in humans.
This article has been cited by other articles:
|
|
 |
|
  P. Lan, N. Tonomura, A. Shimizu, S. Wang, and Y.-G. Yang Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation Blood, July 15, 2006; 108(2): 487 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Turgeon, S. J. Banuelos, L. D. Shultz, B. L. Lyons, N. Iwakoshi, D. L. Greiner, J. P. Mordes, A. A. Rossini, and M. C. Appel Alloimmune Injury and Rejection of Human Skin Grafts on Human Peripheral Blood Lymphocyte-Reconstituted Non-Obese Diabetic Severe Combined Immunodeficient {beta}2-Microglobulin-Null Mice Experimental Biology and Medicine, October 1, 2003; 228(9): 1096 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Omer, V. F. Duvivier-Kali, N. Trivedi, K. Wilmot, S. Bonner-Weir, and G. C. Weir Survival and Maturation of Microencapsulated Porcine Neonatal Pancreatic Cell Clusters Transplanted into Immunocompetent Diabetic Mice Diabetes, January 1, 2003; 52(1): 69 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Abdi, R. N. Smith, L. Makhlouf, N. Najafian, A. D. Luster, H. Auchincloss Jr., and M. H. Sayegh The Role of CC Chemokine Receptor 5 (CCR5) in Islet Allograft Rejection Diabetes, August 1, 2002; 51(8): 2489 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C. Kirkiles-Smith, D. A. Tereb, R. W. Kim, J. M. McNiff, J. S. Schechner, M. I. Lorber, J. S. Pober, and G. Tellides Human TNF Can Induce Nonspecific Inflammatory and Human Immune-Mediated Microvascular Injury of Pig Skin Xenografts in Immunodeficient Mouse Hosts J. Immunol., June 15, 2000; 164(12): 6601 - 6609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yasukawa, H. Ohminami, J. Arai, Y. Kasahara, Y. Ishida, and S. Fujita Granule exocytosis, and not the Fas/Fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4+ as well as CD8+ cytotoxic T lymphocytes in humans Blood, April 1, 2000; 95(7): 2352 - 2355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. V. Hartig, G. W. Haller, D. H. Sachs, S. Kuhlenschmidt, and P. S. Heeger Naturally Developing Memory T Cell Xenoreactivity to Swine Antigens in Human Peripheral Blood Lymphocytes J. Immunol., March 1, 2000; 164(5): 2790 - 2796. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
